VSense develops a revolutionary point of care platform for in vitro diagnostics using semiconductor-based biochips. With its integrated ultra-sensitive disposable biochip, the VSense platform delivers lab quality results within 20 minutes on essentially any protein-protein interactions including immunoassay and liquid biopsy. VSense is now looking for assay development partners for novel biomarkers.
Included in the Export Interest Directory? No
Business Needs: Direct Sales, Distributor/Agent/Representative, Joint Ventures
Countries of Interest: China, France, Germany, Japan, Singapore, Switzerland, United States